Skip to main content

Oncology Startups

Updated July 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 300 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
300
Total Funding
$1.4B
Avg Funding
$55.2M
Global Reach
6
countries

Top Cities for Oncology

Irvine
Nerviano
Houston
San Diego
Boston
Chester

Recently Funded Companies

Export
Irvine, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

$238.0M raised
Dec 2024

Founder Contacts

30,000+ verified contacts

Nerviano, Italy

Nerviano Medical Sciences is a provider of R&D services include oncology drug discovery, preclinical research, clinical development.

$220.9M raised
Jan 2022

Founder Contacts

30,000+ verified contacts

Houston, United States

Diakonos Oncology biotech firm developing dendritic cell vaccines targeting difficult cancer types.

$7.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

$84.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.

$50.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Chester, United Kingdom

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

$55.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Toronto, Canada

Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.

$1.2M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Geel, Belgium

DeuterOncology is a preclinical-stage biotech company.

$6.1M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Tempe, United States

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

$785K raised
Nov 2024

Founder Contacts

30,000+ verified contacts

San Diego, United States

Certis Oncology Solutions is a precision oncology and translational science company serving patients, oncologists and drug developers

$10.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Redwood City, United States

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

$350.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Houston, United States

At Speratum, we're developing a robust RNAi platform targeting key oncogenic drivers in solid tumors.

$581K raised
Nov 2024

Founder Contacts

30,000+ verified contacts

Palo Alto, United States

Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.

$75.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Atlanta, United States

Cambium Oncology is a pre-clinical start-up focused on developing company.

$5.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Qum Therapeutics Develops immunotherapies that target pathogenic cells and engage the patient’s immune system to control disease.

$10.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Fort Worth, United States

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

$100.0M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Birmingham, United States

AI Metrics is an early-stage company that creates a transformational image analysis technology for radiology and oncology.

$952K raised
Nov 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Pioneering novel antibody-based cancer therapies informed by large-scale patient-derived biology.

$4.5M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

Macomics is an immuno-oncology company.

Jan 2023

Founder Contacts

30,000+ verified contacts

Lexington, United States

Nexosome Oncology focus on the applications of exosome-based diagnostics in the cancer field.

$3.7M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Epalinges, Switzerland

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

$38.0M raised
Nov 2022

Founder Contacts

30,000+ verified contacts

Nashville, United States

Reimagine Care is a health care company that provides technology-enabled services to support community-based oncology care settings.

$2.4M raised
Nov 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

$91.0M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Aurora, United States

Aurora Oncology provides new diagnostic and treatment approaches for cancer patients.

$250K raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Boston, United States

BAKX Therapeutics is a provider of cancer treatment.

$25.0M raised
Nov 2021

Founder Contacts

30,000+ verified contacts

Showing 251 to 275 of 300 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 300 oncology companies tracked in the VCBacked database.

Average Funding
$55.2M
Total Funding Tracked
$1.4B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.Houston
2 companies$7.6M
2.San Diego
2 companies$94.0M
3.Boston
2 companies$75.0M
4.New York
2 companies$95.5M
5.Irvine
1 companies$238.0M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked